Catalyst Pharmaceuticals

Catalyst Pharmaceuticals conducts research on and manufactures biopharmaceuticals for the use of treating neurological diseases. Some of the diseases their pharmaceuticals have been used to treat include Lambert-Eaton Myasthenic Syndrome (LEMS), congenital myasthenic syndromes (CMS), MuSK-positive myasthenia gravis (MuSK-MG), and more. This company was founded in 2002 and is headquartered in Coral Gables, Florida.